Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers

NCT05395624 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis (ALS)
Parkinson Disease (PD)
Alzheimer Disease (AD)
Multiple Sclerosis (MS)

Interventions

DRUG: 18F-OP-801

Sponsor

Ashvattha Therapeutics, Inc.